Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 |
filingDate |
2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c86d07fc81e88fd52643e5bddce28746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf81265b80a6b29879f90d554977c40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e99c11937af8a86f3f4e3ad81b7fcf3c |
publicationDate |
2017-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9567376-B2 |
titleOfInvention |
Enhanced AAV-mediated gene transfer for retinal therapies |
abstract |
Described herein are capsid proteins and adeno-associated viruses capable of targeting various types of ocular cells including bipolar and horizontal cells. Also described herein are methods of treating various ocular disorders in a subject in need thereof by administering to the subject an effective concentration of a composition comprising the recombinant adeno-associated virus (AAV) of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11326182-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10920227-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10577627-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11027000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208438-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570395-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017007720-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10597660-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11193129-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497576-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11697825-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752181-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11198873-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298041-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10584337-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745447-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299751-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10335466-B2 |
priorityDate |
2013-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |